Literature DB >> 12941758

Effect of exercise intensity on skeletal muscle AMPK signaling in humans.

Zhi-Ping Chen1, Terry J Stephens, Sid Murthy, Benedict J Canny, Mark Hargreaves, Lee A Witters, Bruce E Kemp, Glenn K McConell.   

Abstract

The effect of exercise intensity on skeletal muscle AMP-activated protein kinase (AMPK) signaling and substrate metabolism was examined in eight men cycling for 20 min at each of three sequential intensities: low (40 +/- 2% VO(2) peak), medium (59 +/- 1% VO(2) peak), and high (79 +/- 1% VO(2) peak). Muscle free AMP/ATP ratio only increased at the two higher exercise intensities (P < 0.05). AMPK alpha 1 (1.5-fold) and AMPK alpha 2 (5-fold) activities increased from low to medium intensity, with AMPK alpha 2 activity increasing further from medium to high intensity. The upstream AMPK kinase activity was substantial at rest and only increased 50% with exercise, indicating that, initially, signaling through AMPK did not require AMPK kinase posttranslational modification. Acetyl-CoA carboxylase (ACC)-beta phosphorylation was sensitive to exercise, increasing threefold from rest to low intensity, whereas neuronal NO synthase (nNOS) micro phosphorylation was only observed at the higher exercise intensities. Glucose disappearance (tracer) did not increase from rest to low intensity, but increased sequentially from low to medium to high intensity. Calculated fat oxidation increased from rest to low intensity in parallel with ACC beta phosphorylation, then declined during high intensity. These results indicate that ACC beta phosphorylation is especially sensitive to exercise and tightly coupled to AMPK signaling and that AMPK activation does not depend on AMPK kinase activation during exercise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941758     DOI: 10.2337/diabetes.52.9.2205

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  99 in total

Review 1.  Power athletes and distance training: physiological and biomechanical rationale for change.

Authors:  Marcus C C W Elliott; Phillip P Wagner; Loren Chiu
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 2.  Subcellular targeting and trafficking of nitric oxide synthases.

Authors:  Stefanie Oess; Ann Icking; David Fulton; Roland Govers; Werner Müller-Esterl
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

Review 3.  The molecular bases of training adaptation.

Authors:  Vernon G Coffey; John A Hawley
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

4.  Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.

Authors:  Hans C Dreyer; Satoshi Fujita; Jerson G Cadenas; David L Chinkes; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

Review 5.  Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise.

Authors:  Anand Thirupathi; Claudio Teodoro de Souza
Journal:  J Physiol Biochem       Date:  2017-07-14       Impact factor: 4.158

Review 6.  Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit.

Authors:  Sean L McGee; Mark Hargreaves
Journal:  Nat Rev Endocrinol       Date:  2020-07-06       Impact factor: 43.330

7.  Metabolic stress-dependent regulation of the mitochondrial biogenic molecular response to high-intensity exercise in human skeletal muscle.

Authors:  M Fiorenza; T P Gunnarsson; M Hostrup; F M Iaia; F Schena; H Pilegaard; J Bangsbo
Journal:  J Physiol       Date:  2018-06-26       Impact factor: 5.182

8.  The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes.

Authors:  Philip L Hooper; Gabor Balogh; Eric Rivas; Kylie Kavanagh; Laszlo Vigh
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

9.  Physical activity intensity and type 2 diabetes risk in overweight youth: a randomized trial.

Authors:  J Hay; K Wittmeier; A MacIntosh; B Wicklow; T Duhamel; E Sellers; H Dean; E Ready; L Berard; D Kriellaars; G X Shen; P Gardiner; J McGavock
Journal:  Int J Obes (Lond)       Date:  2015-11-30       Impact factor: 5.095

10.  ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected].

Authors:  John C Castle; Yoshikazu Hara; Christopher K Raymond; Philip Garrett-Engele; Kenji Ohwaki; Zhengyan Kan; Jun Kusunoki; Jason M Johnson
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.